Rejuvenation Roundup April 2024
Both advocacy and biotech need the right approaches to work.
Last month has brought forward a lot of exciting news in the longevity industry, including our own upcoming merger with SENS. Here’s what’s happened in April.
LEAF News
SENS Research Foundation and Lifespan.io Announce Intent to Merge, Forming a Novel Longevity Entity: SENS Research Foundation and Lifespan.io (Lifespan Extension Advocacy Foundation) have unveiled plans to merge, upon completion of regulatory approvals. This merger signifies a new chapter in the quest for extended human healthspan—a journey fueled by innovation, passion, and a shared commitment to bringing the diseases of aging under medical control. With their complementary strengths and shared vision, the newly formed nonprofit promises to lead the charge towards a future where aging is no longer a barrier to a life well lived.
Team and activities
Vitalia: Living the Longevity Dream: On the tropical island of Roatán, a bunch of people gathered in an unprecedented, longevity-themed pop-up city – and then some of them stayed, making the venture permanent. Lifespan.io’s Arkadi Mazin was there to report.
Interviews
New Gene Therapy Reverses Atherosclerosis In Mice: Repair Biotechnologies, a company based in Syracuse, New York, has announced findings from early research suggesting that its technology can quickly stop the advancement of atherosclerosis. While these preclinical results are in mice, this approach has the potential for treating atherosclerosis in humans.